经导管栓塞术治疗肝血管瘤中远期疗效观察及影响因素分析  

Medium-long-term curative effect and the analysis about influencing factors of transcatheter embolization for treatment of hepatic hemangioma

作　　者：周春泽[1] 吕维富[1] 董金斌[1] 

机构地区：[1]安徽医科大学附属省立医院,合肥230001

出　　处：《山东医药》2009年第35期37-39,共3页Shandong Medical Journal

摘　　要：目的观察经导管栓塞术治疗肝血管瘤的中远期疗效及相关因素。方法对79例接受供血动脉栓塞治疗的肝血管瘤患者随访观察6～36个月，评价其有效率并对11项可能影响该疗效的因素行回顾性单因素分析，对有意义的（P〈0．05）因素进行多元Logistic逐步回归分析，寻找影响中远期疗效的主要危险因素。结果本组总有效率为78．4％；肿瘤直径、个数、供血动脉支数，动脉期肿瘤染色情况、是否行超选择插管等为影响中远期疗效的危险因素。结论经导管栓塞术治疗肝血管瘤中远期疗效确切，但受多种危险因素影响；对于危险因素较多、预测介入治疗效果不佳者可考虑行其他治疗方式。Objective To evaluate the medium-long-term curative effect and influencing factors of transcatheter embolization for treatment of hepatic hemangioma. Methods Seventy-nine patients with hepatic hemangioma were followed up after the embolism of supplying artery for 6-36 months. The effective rate was evaluated and 11 factors which may impact curative effect were dealed with retrospective one-way analysis, then the significant factors （ P 〈 0.05 ） were dealed with multivariate stepwise logistic regression analysis to find the mainly risk factors influencing medium-long-term curative effect. Resuits The total effective rate was 78.4%. The size and number of tumour, the number of arteries,the tumor stain of arterial phase and whether fitting for nltra-selective catheterization were the critical factors impacting the curative effect. Conclusions Patients with hepatic hemangioma treated by transcatheter embolization have good medium-long-term curative effect, but can be impacted by many factors. Who have more risk factors or have worse interventional therapeutic efficacy predicted should be adopted to other therapy way.

关 键 词：肝血管瘤 介入治疗 疗效 回归分析 

分 类 号：R735.7[医药卫生—肿瘤]